These findings thus provide biological evidence of modulation of the target genes TCF7, MYC, and JAG1 in non‐engineered and engineered CRC tumoroid lines and demonstrate directional consistency based on SMAD4 status as predicted in Table 1. The gene discussed is JAG1; the disease is colorectal carcinoma.